DE69426337D1 - Hemmstoff für Ribonukleotid-Reduktase von Herpesviren - Google Patents

Hemmstoff für Ribonukleotid-Reduktase von Herpesviren

Info

Publication number
DE69426337D1
DE69426337D1 DE69426337T DE69426337T DE69426337D1 DE 69426337 D1 DE69426337 D1 DE 69426337D1 DE 69426337 T DE69426337 T DE 69426337T DE 69426337 T DE69426337 T DE 69426337T DE 69426337 D1 DE69426337 D1 DE 69426337D1
Authority
DE
Germany
Prior art keywords
alkyl
nhch
amino acid
inhibitor
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426337T
Other languages
English (en)
Other versions
DE69426337T2 (de
Inventor
Robert Deziel
Neil Moss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Publication of DE69426337D1 publication Critical patent/DE69426337D1/de
Application granted granted Critical
Publication of DE69426337T2 publication Critical patent/DE69426337T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69426337T 1993-03-03 1994-02-23 Hemmstoff für Ribonukleotid-Reduktase von Herpesviren Expired - Fee Related DE69426337T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2554093A 1993-03-03 1993-03-03

Publications (2)

Publication Number Publication Date
DE69426337D1 true DE69426337D1 (de) 2001-01-04
DE69426337T2 DE69426337T2 (de) 2001-05-31

Family

ID=21826675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426337T Expired - Fee Related DE69426337T2 (de) 1993-03-03 1994-02-23 Hemmstoff für Ribonukleotid-Reduktase von Herpesviren

Country Status (27)

Country Link
US (1) US5476841A (de)
EP (1) EP0618226B1 (de)
JP (1) JPH08507760A (de)
KR (1) KR960701090A (de)
CN (1) CN1118601A (de)
AT (1) ATE197802T1 (de)
AU (1) AU683450B2 (de)
BG (1) BG99889A (de)
BR (1) BR9406346A (de)
CA (1) CA2157196C (de)
CZ (1) CZ224295A3 (de)
DE (1) DE69426337T2 (de)
DK (1) DK0618226T3 (de)
ES (1) ES2152269T3 (de)
FI (1) FI954048A0 (de)
GR (1) GR3035295T3 (de)
HU (1) HUT72894A (de)
IL (1) IL108818A0 (de)
LV (1) LV11037B (de)
NO (1) NO953437L (de)
NZ (1) NZ262073A (de)
PL (1) PL310447A1 (de)
PT (1) PT618226E (de)
SG (1) SG65553A1 (de)
SK (1) SK106095A3 (de)
WO (1) WO1994020528A1 (de)
ZA (1) ZA941449B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830864A (en) * 1992-03-12 1998-11-03 Boehringer Ingelheim (Canada), Ltd. Antiherpes peptide derivatives having a ureido n-terminus
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
EP2030615A3 (de) * 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411334B1 (de) * 1989-07-07 1995-02-22 Bio-Mega/Boehringer Ingelheim Research Inc. Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten
JPH03181498A (ja) * 1989-12-07 1991-08-07 Merck & Co Inc ペプチド抗ウイルス剤
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use

Also Published As

Publication number Publication date
NO953437D0 (no) 1995-09-01
SG65553A1 (en) 1999-06-22
ATE197802T1 (de) 2000-12-15
CA2157196A1 (en) 1994-09-15
PL310447A1 (en) 1995-12-11
FI954048A (fi) 1995-08-29
ZA941449B (en) 1994-10-14
IL108818A0 (en) 1994-06-24
DK0618226T3 (da) 2000-12-27
HU9502570D0 (en) 1995-11-28
NZ262073A (en) 1997-07-27
LV11037A (lv) 1996-02-20
US5476841A (en) 1995-12-19
ES2152269T3 (es) 2001-02-01
DE69426337T2 (de) 2001-05-31
AU683450B2 (en) 1997-11-13
EP0618226A1 (de) 1994-10-05
JPH08507760A (ja) 1996-08-20
WO1994020528A1 (en) 1994-09-15
HUT72894A (en) 1996-06-28
LV11037B (en) 1996-06-20
CZ224295A3 (en) 1996-02-14
GR3035295T3 (en) 2001-04-30
NO953437L (no) 1995-09-01
FI954048A0 (fi) 1995-08-29
PT618226E (pt) 2001-03-30
AU6151694A (en) 1994-09-26
BR9406346A (pt) 1996-02-21
SK106095A3 (en) 1996-02-07
BG99889A (en) 1996-02-28
CA2157196C (en) 2000-06-13
CN1118601A (zh) 1996-03-13
KR960701090A (ko) 1996-02-24
EP0618226B1 (de) 2000-11-29

Similar Documents

Publication Publication Date Title
GB9320782D0 (en) Stabilising of proteins on solution
GB9308957D0 (en) Novel produgs
NZ238455A (en) Antiherpes peptide derivatives having a 1,4-dioxo-c 4 n-terminus;
DE69426337D1 (de) Hemmstoff für Ribonukleotid-Reduktase von Herpesviren
LV10461A (lv) Izosterie peptidu atvasinajumi ar pretherpesa ipasibam
ZA931746B (en) Antiherpes peptide derivatives having a ureido N-terminus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee